Filter your results
- 3
- 1
- 4
- 4
- 1
- 1
- 1
- 1
- 4
- 3
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 4
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
sorted by
|
|
Effectiveness and tolerance of Janus kinase inhibitors for the treatment of recalcitrant atopic dermatitis in a real-life French multicenter adult cohortJournal of The American Academy of Dermatology, 2022, ⟨10.1016/j.jaad.2022.10.034⟩
Journal articles
hal-03903864v1
|
||
Melanomas Associated With Blue Nevi or Mimicking Cellular Blue Nevi: Clinical, Pathologic, and Molecular Study of 11 Cases Displaying a High Frequency of GNA11 Mutations, BAP1 Expression Loss, and a Predilection for the ScalpAmerican Journal of Surgical Pathology, 2015, ⟨10.1097/PAS.0000000000000568⟩
Journal articles
hal-01255859v1
|
|||
|
Prognostic Factors of Paraneoplastic Pemphigus.Archives of Dermatology -Chicago-, 2012, pp.1-8. ⟨10.1001/archdermatol.2012.1830⟩
Journal articles
hal-00727669v1
|
||
Omalizumab in patients with severe and refractory solar urticaria: A phase II multicentric studyJournal of The American Academy of Dermatology, 2016, 74 (3), pp.574--575. ⟨10.1016/j.jaad.2015.11.021⟩
Journal articles
hal-01282331v1
|